|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����������Ǵ� |
|
������ |
|
HLA����� |
|
���в�ѧ |
| ��������������� | |
|
ʩС�� |
|
������У |
|
��ѧ����У |
| PubMed | |
|
Article by ʩС�� |
|
Article by ������У |
|
Article by ��ѧ����У |
����������Ǵ��о���չ
1. ����ҽ�ƴ�ѧ���в�ѧ������;
2. ����ҽ�ƴ�ѧ����ҽԺƤ����
��������������������Ǵ������в�ѧ���ٴ����֡�������ϡ����Ƽ�Ԥ��ȵ��о���չ,���ؽ����˿�Ro�����塢�����ϸ����ԭ��λ���������������Ǵ�����Ĺ�ϵ,�����δ������������Ǵ��о������ٵ���ս��
1. ����ҽ�ƴ�ѧ���в�ѧ������;
2. ����ҽ�ƴ�ѧ����ҽԺƤ����
1. ����ҽ�ƴ�ѧ���в�ѧ������;
2. ����ҽ�ƴ�ѧ����ҽԺƤ����
[2] Brucato A,Buyon JP,Horsfall AC,et al.Foourth international workshop on neonatal lupus syndromes and the Ro/SSA-La/SSB system.Clin Exp Rhemuatol,1999,17(1):130-136.
[3] Waltuck J,Buyon JP.Autoantibody-associated congenital heart block:outcome in mothers and children.Ann Intern Med,1994,120(7):544-551.
[4] Thornton CM,Eichenfield LF,Shinall EA,et al.Cutaneous telangiectasia in neonatal lupus erythematosus.J Am Acad Dermatol,1995,33(1):19-25.
[5] Furukawa F,Itoh T,Wakita H,et al.Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.Clin Exp Immunol,1999,118(1):164-170.
[6] Taylor-Albert E,Reichlin M,Toews WH,et al.Delayed dilated cardiomyopathy as a manifestation of neonatal lupus:case reports,autoantibody analysis and management.Pediatrics,1997,99(5):733-735.
[7] Lee LA,Weston WL.Cutaneous lupus erythematosus during the neonatal and childhood periods.Lupus,1997,6(2):132-138.
[8] Sheth AP,Esterly NB,Ratoosh SL,et al.U1RNP positive neonatal lupus erythematosus:association with anti-La antibodies.Br J Dematol,1995,132(4):520-526.
[9] Lee AL,Frank MB,McCubbin VR,et al.Autoantibodies of neonatal lupus erythematosus.J Invest Dermatol,1994,102(6):963-966.
[10] Silverman ED,Buyon JP,Laxer RM,et al.Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus.Clin Exp Immunol,1995,100(3):499-505.
[11] Yazici Y,Onel K,Sammaritano L.Neonatal lupus erythematosus in triplets.J Rheumatol,2000,27(3):807-809.
[12] Garcia S,Nascimento JH,Bonfa E,et al.Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.J Invest Dermatol,1994,93(2):718-724.
[13] Miyagawa S,Shinogara K,Kidoguchi K,et al.Neonatal lupus erythematosus:studies on HLA class �� genes and autoantibody profiles in Japanese mothers.Autoimmunity,1997,26(2):95-101.
[14] Buyon JP,Tseng CE,Di Donato F,et al.Cardiac expression of 52��,an alternative transcript of the congenital heart block-associated 52kD SSA/Ro autoantigen,is maximal during fetal development.Arthritis Rheum,1997,40(4):655-660.
[15] Buyon JP.Neonatal lupus and autoantibodies reactive with SSA/Ro-SSB/La.Scand J Rheumatol(Suppl),1998,107:23-30.
[16] Miyagawa S,Kidoguchi K,Kaneshige K,et al.Neonatal lupus erythematosus:analysis of HLA class �� genes in Japanese child/mother pairs.Lupus,1999,8(9):751-754.
[17] Kelly TE,Alford BA,Greer KM,et al.Chondrodysplasig punctata stemming from maternal lupus erythematosus.Am J Med Ge net,1999,83(5):397-401.
[18] Szer IS.Clinical development in the management of lupus in the nexnatal,child,and adolescent.Curr Opin Rheumatol,1998,10(5):431-434.